Real-World Study of Everolimus in Advanced Progressive Neuroendocrine TumorsFrancesco Panzuto, Gianfranco Delle Fave, Francesca Lugli et al.|The Oncologist|2014Cited by 103
Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline CarcinomaMichela Maur, PierFranco Conte, Angela Toss et al.|American Journal of Case Reports|2015Cited by 21
Real-World Study of Everolimus in Advanced Progressive Neuroendocrine TumorsFrancesco Panzuto, Gianfranco Delle Fave, Maria Rinzivillo et al.|The Oncologist|2015Cited by 9